Pharmacological Modulation of BET Family in Sepsis
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis 3.0) recommended defining sepsis as a life-threatening organ dysfunction caused by the host's uncontrolled response to infection. The bromodomain and extra-terminal (BET) protein family (such as BRD2, BRD3, and BR...
Main Authors: | Nian Wang, Runliu Wu, Paul B. Comish, Rui Kang, Daolin Tang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-03-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2021.642294/full |
Similar Items
-
The Functions of BET Proteins in Gene Transcription of Biology and Diseases
by: Ka Lung Cheung, et al.
Published: (2021-09-01) -
BET Bromodomain Inhibitors: Novel Design Strategies and Therapeutic Applications
by: Kenneth K. W. To, et al.
Published: (2023-03-01) -
Pharmacologic Targeting of BET Proteins Attenuates Hyperuricemic Nephropathy in Rats
by: Chongxiang Xiong, et al.
Published: (2021-02-01) -
Inflammasome-Dependent Coagulation Activation in Sepsis
by: Runliu Wu, et al.
Published: (2021-03-01) -
Inhibition of Bromodomain and Extra Terminal (BET) Domain Activity Modulates the IL-23R/IL-17 Axis and Suppresses Acute Graft-Versus-Host Disease
by: Katiri J. Snyder, et al.
Published: (2021-10-01)